|Day's Range||52.06 - 54.44|
|52 Week Range||46.01 - 76.48|
|PE Ratio (TTM)||18.84|
|Dividend & Yield||1.56 (2.79%)|
|1y Target Est||N/A|
Q2 2017 Bristol-Myers Squibb Co Earnings Call
Chasing exciting new developments in medicine can be a very expensive endeavor. Such is the takeaway from AstraZeneca’s announcement that a hotly anticipated clinical trial didn’t meet expectations.
The New York-based company said it had net income of 56 cents per share. Earnings, adjusted for non-recurring costs, came to 74 cents per share. The results beat Wall Street expectations. The average estimate ...